The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Gilead Sciences; Hansa Biopharma; Incyte; Neximmune; Rigel
Research Funding - Incyte; NexImmune
Preliminary analysis of a phase 1/2 study of NEXI-001 donor-derived multi-antigen-specific CD8+ T-cells for the treatment of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT).
 
Monzr Al Malki
No Relationships to Disclose
 
Sumithira Vasu
Consulting or Advisory Role - Johnson and Johnson; Omeros
Patents, Royalties, Other Intellectual Property - The Ohio State University has entered into an exclusive licensing agreement with Kiadis Inc (Inst)
 
Dipenkumar Modi
Consulting or Advisory Role - MorphoSys; Seagen; Zentalis
 
Miguel-Angel Perales
Stock and Other Ownership Interests - NexImmune
Honoraria - MorphoSys
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Cidara Therapeutics; Incyte; Kite/Gilead; Medigene; Merck; MolMed; Nektar; NexImmune; Novartis; Omeros; Servier/Pfizer; Takeda; Vor Biopharma
Research Funding - Incyte (Inst); Kite, a Gilead company (Inst); Miltenyi Biotec (Inst); Nektar (Inst); Novartis (Inst)
 
Donna Bui
No Relationships to Disclose
 
Vineetha Edavana
Employment - NexImmune
Stock and Other Ownership Interests - NexImmune
Patents, Royalties, Other Intellectual Property - NexImmune
 
Sojung Kim
Employment - NexImmune
Stock and Other Ownership Interests - NexImmune
Patents, Royalties, Other Intellectual Property - NexImmune
 
Lauren Suarez
Patents, Royalties, Other Intellectual Property - NexImmune
 
Mathias Oelke
Employment - NexImmune
Leadership - NexImmune
Stock and Other Ownership Interests - NexImmune
Research Funding - NexImmune
Patents, Royalties, Other Intellectual Property - NexImmune
 
Dan Bednárik
Employment - NexImmune
Leadership - NexImmune
Stock and Other Ownership Interests - NexImmune
Research Funding - NexImmune
Patents, Royalties, Other Intellectual Property - NexImmune
 
Robert D. Knight
Employment - NexImmune
Leadership - NexImmune
Stock and Other Ownership Interests - NexImmune
Travel, Accommodations, Expenses - NexImmune
 
Juan Carlos Varela
Stock and Other Ownership Interests - NexImmune
Honoraria - NexImmune
Consulting or Advisory Role - NexImmune
Speakers' Bureau - Kite, a Gilead Company